Hydroxocobalamin Acetate API Manufacturers | Suppliers | Exporters

01

HealthTech BioActives

Spain

Fi Europe 2024

Stand# 3.1N10

HealthTech BioActives, leading globally in Flavonoids and Vitamin B12 Derivatives.

Contact Supplier

Spain

Virtual Booth

Digital Content

Hydroxocobalamin Acetate

About the Company : HTBA (HealthTech BioActives) is a leading global company highly specialized in flavonoids and vitamin B12 derivatives After 40 years in the pharmaceutical world of ingredients of ...

HTBA (HealthTech BioActives) is a leading global company highly specialized in flavonoids and vitamin B12 derivatives After 40 years in the pharmaceutical world of ingredients of natural origin, HTBA is determined to formulate today the new methods of tomorrow. HTBA covers the entire value chain, from raw materials to merchandise, with global reach in pharmaceuticals, dietary supplements, human and animal nutrition, and in cosmetics. In HTBA we know that our ingredients have a direct impact, not only in our clients activity but also in the well-being of the consumers of their products.

02

Deccan Nutraceuticals Pvt. Ltd

India

CPhI India 2024

Booth #IP-75

Deccan Nutraceuticals: A global leader in the integrated development, manufacturing, and marketing of pharmaceutical products.

Contact Supplier

India

Virtual Booth

Digital Content

Hydroxocobalamin Acetate

About the Company : Deccan Nutraceuticals Pvt. Ltd. (DNPL) is a group company of Alkaloids Corporation (India), was founded in 2001 and operates from a 22,000 sq. m. facility in Pune (India). Their co...

Deccan Nutraceuticals Pvt. Ltd. (DNPL) is a group company of Alkaloids Corporation (India), was founded in 2001 and operates from a 22,000 sq. m. facility in Pune (India). Their commitment to quality and adherence to Current Good Manufacturing Practices (CGMP) are integral to their operations. The company has been successfully audited by USFDA (5 times) and EDQM (2 times). The company manufactures high quality phytochemicals, semi-synthetic and synthetic APIs. DNPL stands as a responsible pharmaceutical manufacturer, devoted to delivering premium products across all the regions we serve.

Corporate PDF

03

EUROAPI

France

DDL Conference

Attending

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

France

Virtual Booth

Digital Content

Hydroxocobalamin Acetate

About the Company : EUROAPI is the market leader in small molecule APIs with projected sales of about €1 billion in 2022. With around 200 APIs, it has one of the largest portfolios in the market. Th...

EUROAPI is the market leader in small molecule APIs with projected sales of about €1 billion in 2022. With around 200 APIs, it has one of the largest portfolios in the market. Thanks to its excellent R&D skills and six manufacturing facilities across Europe, EUROAPI guarantees API manufacturing of the highest quality to its clients in over 80 countries. Its strong innovation and R&D skills helps it to speed the development of more complex molecule segments through CDMO operations. It also offers experience in supply, regulation and quality. EUROAPI employs 3,350 people and is listed on Euronext.

04

Supriya Lifescience

India

CPhI India 2024

Booth #1.B20

Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Contact Supplier

India

Virtual Booth

Digital Content

Hydroxocobalamin Acetate

About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Su...

Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.